← Leaderboards
Gilles Salles
Sloan-Kettering Inst Can Research
$273,372
Attributed
$273,372
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$273,372 · 1
By mechanism
P50$273,372 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Craig B Thompson$56,520,903
- Hans-Guido Wendel$13,517,904
- Samuel Singer$8,089,401
- Michael Kharas$18,485,709
- Richard Kevin Hite$4,953,768
Others in their field
Other Emerging Leaders on “S Lymphoma”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,138,591
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,332,151
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Javeed Iqbal · University Of Nebraska Medical Center$5,566,166
- John Karijolich · Vanderbilt University Medical Center$5,446,739
Research focus
S LymphomaB-Cell LymphomasDrug DevelopmentBehaviorBiological MarkersBromodomainCell GrowthCell LineCell ProliferationCell SurvivalChemotherapyChemotherapy-Oncologic ProcedureChromosomal TranslocationComplexBcl-2 ProteinExperimental StudyFirst-In-HumanFrap1 GeneGeneticGenetic TranscriptionHistologicHistone DeacetylaseHistone Deacetylase InhibitorBase